Doctors at University Hospital Leuven treated a multiple myeloma patient for the first time last week with a brand new type of immune therapy. The treatment uses immune cells from the patient himself, which are genetically modified to recognize and attack the cancer cell.
Welcome to the Leuven Cancer Institute, the LKI. The LKI unites doctors, caretakers and researches of University Hospitals Leuven and the KU Leuven in their fight against cancer. The LKI strives to coordinate research, therapy and care in the best way possible. We invest in targeted projects and incorporate innovative technologies, spanning several domains of cancer.
Together we can achieve progress faster and play a leading role in the battle against cancer. Every ally, each partner makes us stronger. Thank you for your support.
Prof. dr. Michel Delforge, chairman of the LKI
